• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A型或B型血友病患者对凝血因子的依从性。

Adherence to clotting factors among persons with hemophilia A or B.

作者信息

Armstrong Edward P, Malone Daniel C, Krishnan Sangeeta, Wessler Maj Jacob

出版信息

Hematology. 2015 Apr;20(3):148-53. doi: 10.1179/1607845414Y.0000000176. Epub 2014 Jul 7.

DOI:10.1179/1607845414Y.0000000176
PMID:25001343
Abstract

OBJECTIVE

Evaluate adherence to clotting factor treatment and associated outcomes for patients with hemophilia using an integrated delivery database.

METHODS

This was a retrospective, observational study tracking patients between 2006 and 2011. Patients with diagnosis codes for hemophilia were identified. Bleeding and complication rates were annualized over the study period. Medication adherence was assessed using prescription claims for clotting factors by examining sequential time periods of 180 days for each patient's continuous enrollment. Adherence within the time period was calculated using the 'days supply' field divided by 180 days. Under the assumption that severe patients should be treated prophylactically, patients were considered adherent within the time period if the ratio of 'days supply' to observed days was 60% or greater.

RESULTS

A total of 207 patients (74.9 and 25.1% hemophilia A and B, respectively) met the inclusion/exclusion criteria. There were 101 (48.8%) mild, 32 (15.5%) moderate, and 74 (35.7%) severe patients with hemophilia. The percentage of time periods where adherence to clotting factors was 60% or greater was 14% (SD = 28%) for mild disease, 21% (SD = 32%) for moderate disease, and 51% (SD = 36%) for severe disease. Among patients with severe disease, 27 (36.5%) were adherent ≤ 30% of time periods, 22 (29.7%) adherent 31-70% of the time periods, and 25 (33.8%) were adherent ≥ 71% of time periods. Joint bleeding episodes and hospitalizations were uncommon events among the three groups.

CONCLUSIONS

Among patients with severe disease, the majority (66.2%) were adherent <70% of the time.

摘要

目的

利用综合医疗数据库评估血友病患者对凝血因子治疗的依从性及相关结局。

方法

这是一项回顾性观察研究,追踪2006年至2011年期间的患者。确定患有血友病诊断编码的患者。在研究期间对出血率和并发症发生率进行年化处理。通过检查每位患者连续参保的180天连续时间段内的凝血因子处方申请来评估药物依从性。使用“供应天数”字段除以180天来计算该时间段内的依从性。假设重度患者应接受预防性治疗,如果“供应天数”与观察天数的比率为60%或更高,则认为患者在该时间段内依从。

结果

共有207例患者(分别为74.9%的A型血友病和25.1%的B型血友病)符合纳入/排除标准。有101例(48.8%)轻度、32例(15.5%)中度和74例(35.7%)重度血友病患者。轻度疾病患者凝血因子依从性达到60%或更高的时间段百分比为14%(标准差=28%),中度疾病为21%(标准差=32%),重度疾病为51%(标准差=36%)。在重度疾病患者中,27例(36.5%)在≤30%的时间段内依从,22例(29.7%)在31%-至70%的时间段内依从,25例(33.8%)在≥71%的时间段内依从。三组中关节出血发作和住院均为罕见事件。

结论

在重度疾病患者中,大多数(66.2%)在不到70%的时间内依从。

相似文献

1
Adherence to clotting factors among persons with hemophilia A or B.A型或B型血友病患者对凝血因子的依从性。
Hematology. 2015 Apr;20(3):148-53. doi: 10.1179/1607845414Y.0000000176. Epub 2014 Jul 7.
2
Hemophilia care in China: review of care for 417 hemophilia patients from 11 treatment centers in Shanxi Province.中国血友病治疗情况:山西省11个治疗中心417例血友病患者的治疗情况回顾
Expert Rev Hematol. 2015 Aug;8(4):543-50. doi: 10.1586/17474086.2015.1043263. Epub 2015 May 6.
3
Current issues in prophylactic therapy for persons with hemophilia.血友病患者预防性治疗的当前问题。
Acta Haematol. 2006;115(3-4):162-71. doi: 10.1159/000090930.
4
Similar bleeding phenotype in young children with haemophilia A or B: a cohort study.血友病A或B患儿的相似出血表型:一项队列研究
Haemophilia. 2014 Nov;20(6):747-55. doi: 10.1111/hae.12470. Epub 2014 Jun 3.
5
Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.伴有因子VIII和因子IX抑制剂的血友病、发病率、出血问题及管理
Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:106-12.
6
Prophylaxis in children with haemophilia - the Polish experience.血友病患儿的预防——波兰的经验
Haemophilia. 2014 Jan;20(1):e108-10. doi: 10.1111/hae.12327. Epub 2013 Nov 20.
7
Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting.在真实环境中重度 A 型和 B 型血友病患者的治疗模式和出血结局。
Ann Hematol. 2020 Dec;99(12):2763-2771. doi: 10.1007/s00277-020-04250-9. Epub 2020 Sep 11.
8
Objective quantification of adherence to prophylaxis in haemophilia patients aged 12 to 25years and its potential association with bleeding episodes.目的:对 12 至 25 岁血友病患者的预防治疗依从性进行客观量化,并探讨其与出血事件的潜在关联。
Thromb Res. 2016 Jul;143:22-7. doi: 10.1016/j.thromres.2016.04.015. Epub 2016 Apr 25.
9
Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens.血友病患者的联合结局:预防方案依从性的重要性。
Haemophilia. 2009 Nov;15(6):1219-27. doi: 10.1111/j.1365-2516.2009.02077.x. Epub 2009 Jul 29.
10
Update on treatment regimens: prophylaxis versus on-demand therapy.治疗方案的最新进展:预防治疗与按需治疗
Semin Hematol. 2003 Jul;40(3 Suppl 3):3-9. doi: 10.1016/s0037-1963(03)80732-1.

引用本文的文献

1
Characteristics and Treatment Patterns of Patients with Haemophilia B Receiving Recombinant Coagulation Factor IX.接受重组凝血因子IX治疗的B型血友病患者的特征及治疗模式
J Clin Med. 2025 Jun 26;14(13):4555. doi: 10.3390/jcm14134555.
2
Factor VIII replacement prophylaxis in patients with hemophilia A transitioning to adults: a systematic literature review.血友病 A 患者过渡到成人期时的因子 VIII 替代预防治疗:系统文献回顾。
Orphanet J Rare Dis. 2021 Jun 26;16(1):287. doi: 10.1186/s13023-021-01919-w.
3
Design and Usability of an Electronic Health Record-Integrated, Point-of-Care, Clinical Decision Support Tool for Modeling and Simulation of Antihemophilic Factors.
电子病历集成、即时临床决策支持工具的设计和可用性,用于抗血友病因子建模和模拟。
Appl Clin Inform. 2020 Mar;11(2):253-264. doi: 10.1055/s-0040-1708050. Epub 2020 Apr 8.
4
Hemophilia prophylaxis adherence and bleeding using a tailored, frequency-escalated approach: The Canadian Hemophilia Primary Prophylaxis Study.采用量身定制、逐步增加频率的方法进行血友病预防治疗的依从性及出血情况:加拿大血友病初级预防研究
Res Pract Thromb Haemost. 2020 Jan 29;4(2):318-325. doi: 10.1002/rth2.12301. eCollection 2020 Feb.
5
Interrelationship between depression, anxiety, pain, and treatment adherence in hemophilia: results from a US cross-sectional survey.血友病患者抑郁、焦虑、疼痛与治疗依从性之间的相互关系:一项美国横断面调查的结果
Patient Prefer Adherence. 2019 Sep 20;13:1577-1587. doi: 10.2147/PPA.S212723. eCollection 2019.
6
Patient preferences in the treatment of hemophilia A: impact of storage conditions on product choice.甲型血友病治疗中的患者偏好:储存条件对产品选择的影响。
Patient Prefer Adherence. 2018 Mar 26;12:431-441. doi: 10.2147/PPA.S151812. eCollection 2018.
7
Treatment adherence in hemophilia.血友病的治疗依从性。
Patient Prefer Adherence. 2017 Sep 27;11:1677-1686. doi: 10.2147/PPA.S139851. eCollection 2017.
8
Point-of-care ultrasonography (POCUS) in hemophilia A: a commentary on current status and its potential role for improving prophylaxis management in severe hemophilia A.甲型血友病的床旁超声检查(POCUS):对当前状况及其在改善重度甲型血友病预防管理方面潜在作用的述评
Ther Adv Hematol. 2017 Apr;8(4):153-156. doi: 10.1177/2040620717690316. Epub 2017 Feb 13.
9
Physician trust and depression influence adherence to factor replacement: a single-centre cross-sectional study.医生信任和抑郁影响凝血因子替代治疗的依从性:一项单中心横断面研究。
Haemophilia. 2017 Jan;23(1):98-104. doi: 10.1111/hae.13078. Epub 2016 Sep 30.